ema glp-1 vision loss recommendation 2025 The metabolic health revolution has arrived

Ozempic blindness isn't a real diagnosis. It's a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). The

20.15

★★★★☆4.8 (126)

A new study finds that GLP-1 medications—such as Ozempic and Wegovy—may double the risk of developing neovascular age-related macular degeneration (nAMD), a serious eye disease, in older adults with diabetes. Demetrios Vavvas,

23.78

★★★★★4.9 (98)

EMA warns Ozempic linked to 'very rare' side effect

22.89

★★★★★5.0 (157)

A new study is looking at a possible link between certain diabetes medications (GLP-1 receptor agonists) and a rare eye condition called NAION, which can cause sudden vision loss. The research does

20.45

★★★★★4.7 (84)

A new study is looking at a possible link between certain diabetes medications (GLP-1 receptor agonists) and a rare eye condition called NAION, which can cause sudden vision loss. The research does

25.88

★★★★★4.9 (203)

The everything drugs: from weight loss to whole body medicines

20.51

★★★★★5.0 (176)

GLP-1 Vision Loss Lawsuit: New MDL Created for Claims

24.62

★★★★★4.8 (132)